Indivior PLC (LON:INDV – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 840.40 ($10.57) and traded as low as GBX 659.50 ($8.29). Indivior shares last traded at GBX 699.50 ($8.80), with a volume of 893,588 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 1,800 ($22.64) target price on shares of Indivior in a research report on Tuesday, December 17th.
Read Our Latest Analysis on INDV
Indivior Stock Down 0.1 %
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Manufacturing Stocks Investing
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.